ABSTRACT
INTRODUCTION
Interruption in pulmonary blood flow can cause ischemia reperfusion (IR) injury and lung dysfunction contributed to by induced inflammation [1] [2] [3] . Lung IR injury in the context of hemorrhagic trauma, in-hospital cardiac arrest, and pulmonary emboli portends worse patient outcomes (reviewed in 4, 5 ). Recent studies suggest that the intestinal microbial flora can modulate inflammatory responses of distant organs, including the lung (reviewed in [6] [7] [8] ). This raises the question of whether or not the intestinal microbial flora might have effects on inflammation induced by lung IR. Since critically ill patients often receive antibiotics that alter their intestinal flora, it is important to expand our understanding of the impact of these microbiome alterations on systemic and lungspecific immune responses. It is conceivable that manipulating the microbiome in a targeted fashion could have disease-specific benefits, however widespread use of antibiotics to eliminate intestinal and other microbiome populations would likely cause greater harm than good. For example, medical and surgical patients that are identified as being at risk for pulmonary embolus (PE), such as those with cancer, hypercoagulable syndromes, or post trauma, could benefit from such therapies that reduce their IR driven lung inflammation should a PE occur. Conversely, the intestinal flora could be supplemented or augmented in patients at risk for nosocomial pneumonia to facilitate the lung"s ability to clear microbial pathogens.
The innate immune system orchestrates sterile inflammation induced by tissue injury such as in trauma and other scenarios involving IR injury [9] [10] [11] [12] . In addition to serving as receptors for microbial products, the family of Toll-like receptors (TLRs) function as sensors of endogenous cellular and tissue damage 9, 13 . For instance, TLR4 recognizes LPS
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6 as well as HMGB1. As such TLRs are centrally involved in initiating inflammatory responses to sterile and infectious injury. Furthermore, the inflammasome, an intracellular immune signaling complex that controls IL-1β release, has been identified as a key intracellular regulator for both sterile and infectious inflammatory stimuli (reviewed in [14] [15] [16] . At a cellular level, alveolar macrophages have been shown to influence local and remote inflammatory responses to trauma and IR in humans as well as in various animal models (reviewed in 17 ).
Studies in animals and humans have indicated that organ injury in IR is exacerbated
by the extrinsic infiltration and activation of immune cells within the injured organ 1, 18 .
However, the spatiotemporal sequence of lung intrinsic and lung extrinsic events and the cellular and molecular pathways responsible for lung IR injury have not been fully delineated. Moreover, the lung immune response to IR may be unique since as an organ, it experiences frequent alterations in segmental blood flow and ventilation, such as in the case of hypoxic pulmonary vasoconstriction.
We previously reported that TLR4 and alveolar macrophages are key components of the early response to ventilated lung IR and that IL-1β made by IR challenged macrophages augmented endothelial inflammatory cytokine production in vitro 20 .
Commensal bacteria, aka, the host microbiome provides an abundant source of diverse TLR ligands and other metabolic factors that can engage with the host immune system in various niches. In doing so, the microbiome may be able to modulate various inflammatory cells and processes, including possibly those following sterile IR in the lung.
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In this study, we further characterized the kinetics of the inflammatory response to non-hypoxic lung IR and tested the hypothesis that reduction of the intestinal microbial flora with intestinally localized antibiotics would affect this lung inflammatory response.
We observed that lung IR inflammation was transient and the reduction of the intestinal microbial flora markedly decreased lung IR-induced inflammation in vivo and reduced the responsiveness of alveolar macrophages to bacterial TLR agonists ex vivo. Our data suggests a novel role for the intestinal microbiome in regulating the magnitude of the lung inflammatory response following trauma through effects on alveolar macrophages.
MATERIALS AND METHODS

Animals
All animal studies were approved by the Institutional Animal Care and Use
Committee at the University of California, San Francisco. Male mice (12-15 weeks old)
were either purchased (The Jackson Laboratory, Bar Harbor, ME) or bred at the animal facility at University of California, San Francisco. Purchased mice were allowed to acclimatize to their new housing for at least 1 week before any experiments on them were conducted.
Investigators have reported strain variation in the inflammatory response to ventilated lung IR and Dodd-o and colleagues measured the magnitude of inflammatory changes observed in various laboratory strains of mice 21 . They established the following hierarchy from highest IR-generated inflammation to lowest: SW/R > C3H > A/J > 129/J > BL6 > CBA/J > SJL/J > Balb/c. For our studies we used C3H mice which were shown to be strong responders.
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Male mice were used primarily to reflect the fact that trauma disproportionately affects human males. Compared to our previous studies 20 , we used larger groups (n=10-15) to assess the effects of intestinal antibiotics on lung IR, since we were uncertain of the magnitude of the treatment effect. All mice for a given experiment were either littermates or purchased/bred such that they were age matched. Since all mice used in these experiments were randomly chosen either to undergo the various surgeries (sham vs.
IR) or treatments (+/-antibiotic water ad libitum), there was no attempt made to blind the experimenters.
Antibiotic treatments:
Mice were given oral antibiotics in their drinking water (120 Units/mL Polymyxin B and 0.6 mg/mL Neomycin ad libitum; both Sigma-Aldrich, St. Louis, MO) for [8] [9] [10] weeks. This duration of treatment was chosen in order to lower the bacterial burden in the intestinal tract and allow for a period of re-equilibration to a new steady-state with an absent/reduced commensal microbiome. Because we use 12-15 week old adult mice for our experiments, we initiated antibiotic treatment immediately after weaning mice, at around 5 weeks of age. Antibiotics were added to the drinking water and the antibiotic drinking water was then either used fresh or frozen for future use. Mice received fresh antibiotic drinking water once a week. The continued microbicidal activity of the antibiotic drinking water was confirmed at the beginning of and at the end of each week when the water was changed. To do so, LB agar plates were coated with 1mL of the antibiotic drinking water and then streaked with live E.coli bacteria and incubated at 37ºC for 48h. Efficacy was confirmed based on lack of bacterial growth on the LB plates. We
have not tested shorter durations of antibiotic treatment. Untreated control mice were given standard drinking water. There were no differences in weight gain or signs of pathogen overgrowth, such as can occur with C. difficile (no diarrhea), in mice that received antibiotic water as compared to control mice. Apart from the presence or absence of antibiotics in the drinking water, all mice were treated identically, and were all housed in the same room in the animal facility.
Stool was obtained using sterile technique from within the intestine of antibiotic treated or control mice, weighed and homogenized in sterile phosphate buffered saline (PSB), and then equivalent amounts (adjusted for stool weight and PBS volume) were plated on LB agar plates and incubated overnight at 37ºC under aerobic and anaerobic conditions. Antibiotic treatment did not result in the overgrowth of bacterial species under aerobic or aneaerobic conditions.
Ventilated Lung Ischemia Reperfusion (Unilateral left pulmonary artery occlusion)
Surgery
A murine model of unilateral left pulmonary artery occlusion was used, as we have described previously 20 . Briefly, mice were anesthetized (using IP tribromoethanol oxygen (via gas exchange) and the absence of a significant bronchial circulatory system.
While this lung IR procedure has high initial survival rates of 80-90% on average, some mice die from irreparable damage to the pulmonary artery or left bronchus during the slip-knot placement. Mice that did not survive the surgery or the reperfusion period procedure were excluded from the study.
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Quantitative reverse transcription real-time polymerase chain reaction
TaqMan-specific inventoried gene primers for glyceraldehyde 3-phosphate dehydrogenase, beta actin, interleukin (IL) 6, IL-1β, tumor necrosis factor (TNF) α, chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2, and ICAM1 were used to measure the message levels of these genes in lung tissue (Life Technologies, Carlsbad, CA).
Lung tissue was homogenized (Tissue-Tearor -Biospec Products, Bartlesville, OK) and total RNA isolated using Trizol ® . We used the High Capacity RNA-to-cDNA reverse transcription Kit using 1 μg messenger RNA per reaction (Life Technologies).
Quantitative real-time polymerase chain reaction was performed using the ABI Prism 7000 Sequence Detection System (Life Technologies). Run method: Polymerase chain reaction activation at 95°C for 20s was followed by 40 cycles of 1s at 95°C and 20s at 60°C.
16S rRNA levels were measured from lung tissue cDNA using the following primers, which were generously provided by Susan Lynch, PhD (University of California San Francisco): P891F (TGGAGCATGTGGTTTAATTCGA) and P1033R
(TGCGGGACTTAACCCAACA ) with UniProbe (CACGAGCTGACGACARCCATGCA) as previously reported 22 . Run method: UDG incubation at 50°C for 2min, followed by polymerase chain reaction activation at 95°C for 10min and then followed by 40 cycles of 15s at 95°C and 1min at 60°C.
The average threshold count (Ct) value of 2-3 technical replicates was used in all calculations. The average Ct values of the internal controls (glyceraldehyde 3-phosphate dehydrogenase, beta actin) was used to calculate ΔCt values for the array samples. Data analysis was performed using the 2 -ΔΔCt method, and the data were corrected for statistical
analysis using log transformation, mean centering, and autoscaling [23] [24] [25] .
Sandwich enzyme-linked immunosorbant assay (ELISA)
Concentrations of IL-6, IL-1β, IL-33, chemokine (C-C motif) ligand (CCL) 2/monocyte chemotactic protein (MCP) 1, CCL3/macrophage inflammatory protein (MIP) 1α, CXCL2/MIP2α, and TNFα in mouse plasma or cell culture supernatant were determined using the mouse Quantikine kit (R&D Systems, Minneapolis, MN). HMGB1
ELISAs were performed per manufacturer"s instructions (IBL International GmBH, Hamburg, Germany). All assays were performed according the manufacturer"s supplied protocol. Standard curves were generated and used to determine the concentrations of individual cytokines or chemokines in the sample.
Microscopy and Histology Scoring of Lung Injury
Hematoxylin and Eosin (H&E) stained paraffin-mounted lung sections were evaluated by bright field microscopy using an Olympus IX51 inverted microscope and images captured using a Retiga 2000R camera and the Qcapture Pro 7 software (Qimaging, British Columbia, Canada).
We assigned an investigator who was blinded to the group assignments to examine the lung H&E slides and determine the levels of lung injury with a semiquantitative scoring system. For each mouse, the investigator examined 20 fields at 200x total magnification and scoring was performed as described elsewhere 26 . Briefly, the first Germany; 2.5 μg/ml). One hour before harvesting, the culture medium was collected and replaced with fresh medium containing Nigericin (Sigma-Aldrich; 5μM). All media that was collected was centrifuged (800g x 5min at 4°C) to remove debris, and stored at -80°C until assayed by ELISA.
Statistical Analysis
Data in the figures are expressed as mean +/-SD. Data from in vivo studies comparing two conditions were analyzed using 2-tailed nonparametric Mann-Whitney 
RESULTS
Lung Ischemia Reperfusion (IR) causes a transient self-resolving inflammation and neutrophilic influx
We utilize a ventilated lung IR animal model in order to eliminate confounding influences of atelectasis or lung tissue hypoxia on the inflammatory responses. We investigated the time course of inflammation following lung IR and found that the neutrophilic influx to the IR-injured lung peaked at early time points (3-6h) and abated within 12-24h, as assessed by H&E staining ( Figure 1A ) and lung injury score ( Figure   1B ). We also measured the kinetics of induction of specific inflammatory cytokines and chemokines, which we previously established are induced by lung IR 20 . We found that IL-6 was rapidly secreted (by 1-3h post reperfusion). Similar to the lung histology,
plasma levels of inflammatory mediators returned to baseline within 12-24h ( Figure 1C for IL-6 secreted levels: 1-way ANOVA p<0.01; Tukey"s correction for multiple comparisons p=0.05 when comparing t=1h vs t=12h or 24h). Similar expression patterns of IL-6 and CXCL1 were observed at the messenger RNA level in the affected lungs, but interestingly not for CXCL2, TNFα or ICAM1 (Figure 1D ).
Antibiotic treatment depletes intestinal microbiota and attenuates lung IR inflammation by gross pathology
Using our ventilated lung IR model, we previously reported that TLR4 and alveolar macrophages are required for lung IR inflammation 20 . We tested the hypothesis that manipulating the intestinal microbiome would alter the inflammatory response to lung IR in an alveolar macrophage dependent fashion. We added antibiotics that are poorly absorbed from the gastrointestinal tract (neomycin and polymyxin B) to the drinking water of mice, and performed bacterial cultures on the stool of mice to confirm that the inclusion of antibiotics in the drinking water qualitatively reduced the intestinal bacterial load (Figure 2) . We also performed anaerobic cultures to confirm that antibiotic treated mice had reduced levels of strict anaerobic bacteria (data not shown). To address the possible contribution of the pulmonary microbiome in lung IR-generated inflammation, we measured the 16S rRNA levels in lung tissue from control and antibiotic treated mice and observed no significant differences ( Figure S1 ).
We assessed the degree of lung injury (at 3h reperfusion), namely neutrophil recruitment and lung edema, following ventilated IR by histology and performed blinded semi-quantitative lung injury scoring as well. The majority of antibiotic-treated mice (9 A C C E P T E D of 11) had severely attenuated IR-initiated inflammation by histology, compared with control mice (9 of 12) ( Figure 3A) . Lung scoring also demonstrated a significant decrease in the lung injury score in the control vs. antibiotic treated mice (p<0.01, Figure   3B ).
Antibiotic treatment reduces the systemic circulating levels of inflammatory cytokines and chemokines following lung IR
Consistent with the effects of antibiotic treatment on lung histology, plasma levels at 3h of reperfusion of IL-6, CXCL2/MIP2α, and CCL2/MCP1 were also reduced in antibiotic-treated vs. control mice (p<0.01, p<0.05, p<0.05, respectively) ( Figure 4) .
While CCL3/MIP1α and IL-1β levels trended lower in the antibiotic-treated cohort, these findings did not achieve statistical significance. There were no differences observable in other cytokines and DAMPs such as TNFα, IL-33, or HMGB1 (data not shown).
Intestinal microbiota modulate alveolar macrophages activation by microbial TLR2 and TLR4 agonists
Intestinal microbiota have been shown by others to modulate lung immune responses 27 . Since we had previously shown that alveolar macrophages were required for the initiation of lung IR inflammation 20 , we hypothesized that intestinal commensal bacteria might modulate the ability of alveolar macrophage to regulate the lung IR inflammatory response. We compared inflammatory responses of BAL (bronchoalveolar lavage) cells (predominantly alveolar macrophages) collected from mice that were and were not treated with antibiotics, but that did not undergo surgery. These alveolar 
Inflammasome pathways are stably muted in alveolar macrophages after exposure to antibiotics
Having previously showed that IL-1β is an important factor for intercellular communication between macrophages and endothelial cells 20 , we investigated whether inflammasome pathways, which regulate the release of active IL-1β, were functioning differently in BAL macrophages collected from mice that were and were not treated with antibiotics, but that did not undergo surgery. As compared with alveolar macrophages from control mice, alveolar macrophages from antibiotic-treated mice released significantly lower levels of IL-1β following stimulation with the inflammasome activator, nigericin (p<0.01; Figure 6 ) even after 24h in culture ex vivo. We first explored the timing of the inflammatory response and immune cell recruitment as well as its resolution following non-hypoxic lung IR in mice. We observed that short periods (30min) of ischemia resulted in the early recruitment of neutrophils upon reperfusion of the previously ischemic lung. However, this process resolved within 12-24h with IL-6 and CXCL1 levels also peaking early and then returning to baseline (as seen in Figure 1 ). While the rapid recruitment of neutrophils to the IR injured tissue was expected, the fast resolution of this process with no apparent lung injury initially appeared to be inconsistent with clinical observations of sustained organ injury, dysfunction and increased morbidity in patients. While this may reflect differences in mouse and human biology, another possible explanation for this discrepancy is that while neutrophils are attracted to lung tissue following non-hypoxic lung IR, the inflammatory
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response resolves in the absence of other insults, such as infection or lung tissue hypoxia, and does not result in significant lung damage and dysfunction. In fact, these neutrophils that are recruited do not generate reactive oxygen species (A. Prakash, unpublished data).
Investigators have shown that local IR can influence the composition of the intestinal microbiome 28 . Conversely, we wanted to ask the question whether the microbiome could affect IR responses. We based this hypothesis on reports that the intestinal microbiome has immunomodulatory effects outside of the gastrointestinal tract and even in the lung ( 27,29-31 and reviewed in [6] [7] [8] ). Thus, we sought to evaluate its role in influencing the inflammatory response to lung IR. We found that commensal microbiota indeed had a role in generating the initial induction of lung IR inflammation (as shown in Figures 3 and 4) . Additionally, we found that even before exposure to IR, the alveolar macrophages isolated from antibiotic treated mice were less responsive to TLR2 and TLR4 agonists than those isolated from control mice ( Figure 5 ). These data suggest that alveolar macrophages may be the resident lung cell type whose ability to respond to lung IR is modulated by the presence, absence, or perhaps specific composition of the intestinal microbiome.
We hypothesize that circulating bacterial products or host signals derived from intestinal exposure to commensal flora may serve to prime lung immunity to respond to infectious and sterile injurants. Identifying such bacterial products and factors as well as host signals is of great interest and the focus of our ongoing experiments. These may include bacterial components, such as LPS, lipoproteins, or peptidoglycan, or bacterial metabolites that gain entry into the circulation and directly affect alveolar macrophage and other lung immune cells. Additionally, or alternatively, the microbial flora might
affect immune cells within or in proximity to the intestine that then either migrate to the lung and directly or indirectly modulate the lung responses. These latter concepts are supported by a recent report that intestinal commensal flora control the trafficking of specific phagocytes to mesenteric lymph nodes 32 . Thus alterations in commensal flora could possibly indirectly or directly skew the alveolar macrophages from a proinflammatory to a pro-resolving phenotype (also described in the literature as "M1" and "M2", respectively).
Investigators have proposed a two-step process for the activation of inflammatory cells via activation of the inflammasome leading to IL-1β release (reviewed in 33, 34 ). We speculate that the commensal microbiota may provide this first "priming" signal, which signals alveolar macrophages to induce pro-IL-1β levels. Alveolar macrophages would then be in a primed state to respond to second "triggering" signals, such as IR, resulting in inflammasome activation and active IL-1β release, further cytokine and chemokine release, and the rapid recruitment of effector cells, such as neutrophils. Supporting this concept is our data showing that alveolar macrophages from antibiotic-treated mice produce significantly less IL-1β ex vivo after challenge with inflammasome stimulators (nigericin) than those from control mice ( Figure 6 ).
Another emerging microbiome population is the pulmonary microbiome 35 .
Although this bacterial population is largely thought to be present in the upper airways and not in the distal airways and alveoli during health, it is possible that the pulmonary microbiome also contributes to the lung IR inflammation. We chose to use oral antibiotics that are poorly absorbed from the intestinal tract to specifically affect the quantity and composition of intestinal bacteria. However, the aspiration or low-level
systemic absorption of these antibiotics could also affect the composition of the commensal pulmonary microbiome. For example, aspirated polymyxin B could directly affect the lung IR responses by binding to and inactivating LPS. To address this issue, we measured bacterial load in antibiotic treated and control mice by CFU counts and quantifying 16S rRNA. We found low to absent levels in blood and lung tissue and these levels were not affected by our administration of oral antibiotics (data not shown and Figure S1 ). Thus, the data support the hypothesis these signals originate from the intestinal microbiome.
Overall, in the specific case of lung IR, we speculate that inflammatory responses may serve a protective rather than maladaptive role. In barrier organs that serve as a frontline against the entry of pathogens, such as the lung, a primed and rapid IR response (A) H&E staining of left lower lung segments of C3H/HeOuJ mice that underwent ischemia (30min) followed by reperfusion (3h to 24h) (5X magnification). Each image is representative of one surgery: i.e. 3 mice were examined at each reperfusion time point.
The schematic of ischemia time and reperfusion times is included below the histology images.
(B) Semi-quantitative lung injury scoring of the H&E stained left lower lung segments.
Normal lung score = 2 and severely injured (maximum) score = 9. Statistics were performed via ordinary one-way ANOVA for multiple comparisons. Plasma levels of IL-6, CXCL2, CCL2, CCL3, and IL-1β were quantified in plasmas collected from antibiotic-treated or control mice at 3h following reperfusion by ELISA (data from all 11 untreated control and 12 antibiotic-treated mice plasma samples shown). 
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